Tuesday, April 22, 2014

Industry: FDA Oversteps Advertising, Labeling Authority In Social Media Guide

Industry: FDA Oversteps Advertising, Labeling Authority In Social Media Guide-insidehealthpolicy: Drug companies warn there could be "statutory and constitutional consequences" if FDA does not revise its social media guidance to clarify that not all company communications fall under the agency's authority for advertising and labeling. Drug industry groups also raise concerns with how FDA determines when manufacturers are responsible for content posted to third-party websites, particularly taking issue with the fact that exerting influence over a site would constitute control over its content.